Plasma carboxypeptidases as regulators of the plasminogen system.
Carboxy-terminal lysine residues on the surface of cells and fibrin bind plasminogen and control its activation. Since plasma contains basic carboxypeptidases, which remove carboxy-terminal lysines from protein substrates, we investigated if these enzymes are involved in the regulation of plasminogen binding sites. Plasma reduced plasminogen binding to cells, and this effect could be ascribed to the activity of the plasma carboxypeptidases. Purified carboxypeptidase N, which is constitutively active, and plasma carboxypeptidase B, which circulates as a zymogen, were both capable of significantly reducing plasminogen binding to cells. Dose titration experiments verified that plasma concentrations of either carboxypeptidase were sufficient to maximally affect plasminogen binding to cells. Furthermore, plasma carboxypeptidase B, but not carboxypeptidase N, reduced the rate of whole blood clot lysis induced by tissue-type plasminogen activator. These findings establish that plasma carboxypeptidases can modulate plasminogen binding to cells and control the rate of fibrinolysis. These functions delineate a novel role for the plasma carboxypeptidases in the regulation of the plasminogen system.
Redlitz
A
A
Department of Molecular Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA.
Tan
A K
AK
Eaton
D L
DL
Plow
E F
EF
D001777:Blood Coagulation; D002268:Carboxypeptidases / Q000097:blood*; D002460:Cell Line; D006801:Humans; D007962:Leukocytes / Q000378:metabolism*; D010958:Plasminogen / Q000378:metabolism*; D010960:Plasminogen Activators / Q000378:metabolism
D010958:Plasminogen; D002268:Carboxypeptidases; D010960:Plasminogen Activators